While some of these genetic FGFR alterations were shown to predict for sensitivity to FGFR inhibitor treatment [23], in other studies (e.g., in lung and breast cancer) the correlation between FGFR1 amplification and FGFR inhibitor sensitivity was less clear [31,32]. Here, FGFR1 is linked to breast cancer.